Sona Barth
Principal Scientist, Discovery Nephrology Roche
Seminars
Wednesday 18th March 2026
Panel Discussion: How Can we Best Apply AI for Streamlined Drug Discovery in CKD?
11:30 am
- Explore how AI and machine learning are being appliedto target identification, protein engineering, and biomarkerdiscovery in CKD, with a focus on DKD
- Examine case studies and strategies from different labs and companies to understand the practical implementation andevolving performance of AI tools
- Discuss the integration of AI across preclinical and clinical stages to accelerate precision nephrology research and development
- Consider collaborative approaches and future frameworks, including shared strategies or white papers, to advance AI use in kidney disease drug discovery and beyond
Wednesday 18th March 2026
A Patient-Centric approach to CKD Drug Discovery: Integrating Clinical Insights with Human Model Systems
11:00 am
- A patient-centric discovery framework to bridge the translational gap in CKD research
- Leveraging multi-OMICS analyses from large patient cohorts to understand disease mechanisms and identify novel therapeutic targets with high clinical relevance
- Utilizing advanced human model systems to recapitulate CKD molecular states
- An example application of targeting pathogenic mechanisms in the diseased kidney using in vivo systems and tailored in vitro assays
